Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 BRL | -3.91% | -3.15% | -37.88% |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company shows low valuation levels, with an enterprise value at 0.23 times its sales.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.88% | 278M | - | ||
-38.61% | 13.83B | B- | ||
-31.33% | 10.96B | B | ||
+13.51% | 6.34B | C | ||
-8.33% | 6.08B | C+ | ||
-30.66% | 6.05B | B | ||
+72.00% | 5.04B | C | ||
-1.61% | 4.67B | D- | ||
-4.84% | 4B | B | ||
-16.14% | 3.28B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PGMN3 Stock
- Ratings Empreendimentos Pague Menos S.A.